Keck School of Medicine of USC

 Alzheimer’s Therapeutic Research Institute

New Alzheimer’s study aims to delay or prevent symptoms

June 21st, 2016|

The international trial co-managed by USC will test a drug in people who show no symptoms of the disease

USC researchers announced Tuesday they will test a promising drug aimed at preventing or delaying the symptoms of Alzheimer’s disease.

The international study, jointly managed by the USC Alzheimer’s Therapeutic Research Institute (ATRI) and Janssen Research & Development, will test Janssen’s

USC Alzheimer’s Therapeutic Research Institute hosts leading neuroscientists for two-day meeting

February 24th, 2016|

Top researchers from across the U.S. gathered in San Diego recently to commemorate a renewed commitment to understand and fight the leading fatal neurodegenerative disease affecting the aging population.

The USC Alzheimer’s Therapeutic Research Institute (ATRI) Partnership Meeting was held in January and brought together USC leaders, neuroscientists and visiting researchers to discuss the new institute

Advancing Alzheimer’s treatment options through collaboration

November 9th, 2015|

Paul Aisen, MD, the founding director of the USC Alzheimer’s Therapeutic Research Institute, is the newest member of the Keck School of Medicine of USC whose focus is Alzheimer’s disease research. He recently spoke with the Dean’s Report, and answered a few questions about joining the Keck School and the progress of Alzheimer’s disease research